Jubilant Pharmova Ltd.

JUBLPHARMA

₹1132.9

-5.49% (-65.8)

Market Cap

₹19,098 Cr.

P/E

34.55

About

Jubilant Pharmova Limited, formerly known as Jubilant Life Sciences Limited, operates globally in Radiopharma, Allergy Immunotherapy, CDMO Sterile Injectables, CRDMO, Generics, and Novel Drugs busines… Read more

Jubilant Pharmova Limited, formerly known as Jubilant Life Sciences Limited, operates globally… Read more

Low

319

52W Range

High

1247

Quick View

CHART MODE

Price

CHART MODE

EV/EBITDA

Price to Sales

Price to Book

CHART MODE

Capex

CHART MODE

Debt

Company Timeline

Subscribe now for more updates

Custom financial statement

Edit rows

Forensics

10 Yes

Positive for this company

2 Neutral

Neutral for this company

5 No

Negative for this company

0 No Data

Insufficient data to analyse

Market Share

62 %

(as of Mar 18)

Historic

Acetic Anhydride - Domestic Market Share

0.06 %

(as of Jul 22)

Historic

Anti - Diabetes - Market Share

0.06 %

(as of Jul 22)

Historic

Cardiovascular - Market Share

0.01 %

(as of Feb 21)

Historic

Neurological - Market Share

0.02 %

(as of Jul 22)

Historic

Pharmaceutical Sector - Market Share

0.03 %

(as of Jul 22)

Historic

Vitamin & Dietary Supplements - Market Share

18 %

(as of Mar 18)

Historic

Vitamin B3 - Global Market Share

64 %

(as of Mar 18)

Historic

Vitamin B4 - Domestic Market Share

Revenue mix

Product Wise Break-Up

Segment Break-Up

Location Wise Break-Up - Contract Research

Location Wise Break-Up - Pharmaceuticals

Location Wise Break-Up

Operating Profit Break-Up

Capex

Asset Break-Up

Operational Metrics

Australia DMF fillings (.)
Source
US DMF Filings (.)
Source
Canada DMF fillings (.)
Source
Japan DMF Filings (.)
Source
Number of ANDA's Filed in USA (.)
Source
Number of ANDA's Approved By USFDA (.)
Source
Number of ANDA's Filed in Europe
Source
Number of ANDA's Approved in Europe
Source
Number of ANDA's Filed in Canada
Source
Number of ANDA's Approved by Canada
Source
R&D as a % of Total Sales (%)
Source

Peer Comparison

Suppliers

Aegis Logistics Ltd.
Time Technoplast Ltd.
Balaji Amines Ltd.
GMM Pfaudler Ltd.
Ganesh Benzoplast Ltd.
Deep Energy Resources Ltd.
TPL Plastech Ltd.

Showing 5 of 7

FAQs on Jubilant Pharmova Ltd. Business

What does Jubilant Pharmova do?

Jubilant Pharmova Limited operates globally in Radiopharma, Allergy Immunotherapy, CDMO Sterile Injectables, CRDMO, Generics, and Novel Drugs with a strong manufacturing presence in Radiopharmaceutical products for regulated markets.

Who are the competitors of Jubilant Pharmova?

Jubilant Pharmova major competitors are Eris Lifesciences, Astrazeneca Pharma I, Sanofi India, Alembic Pharma, Wockhardt, Caplin Point Lab, Marksans Pharma.
Market Cap of Jubilant Pharmova is ₹19,414 Crs.
While the median market cap of its peers are ₹16,545 Crs.

Is Jubilant Pharmova financially stable compared to its competitors?

Jubilant Pharmova seems to be less financially stable compared to its competitors.
Altman Z score of Jubilant Pharmova is 3.56 and is ranked 7 out of its 8 competitors.

View FAQ's On Shareprice

Company Filing

	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release	Mar Jun Sep	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec
Investor Presentation	Mar Jun Sep	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec
Conference Call	Jun Sep Mar	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec
Conference Call SummaryCon Call Summary Powered by OpenAI	Jun Sep Mar	Mar Jun Sep Dec		Mar Jun Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec